<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02712307</url>
  </required_header>
  <id_info>
    <org_study_id>FoHM/Tonsillit2015</org_study_id>
    <secondary_id>2015-001752-30</secondary_id>
    <nct_id>NCT02712307</nct_id>
  </id_info>
  <brief_title>Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci</brief_title>
  <official_title>A Randomized Controlled Study of 5 and 10 Days Treatment With Phenoxymethylpenicillin for Pharyngotonsillitis Caused by Streptococcus Group A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sigvard Mölstad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Public Health Agency of Sweden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to compare the clinical efficacy of 5 days (800 mg x 4)
      versus 10 days (1000 mg x 3) treatment with phenoxymethylpenicillin (PcV) in adults,
      adolescents and children with streptococcal tonsillitis. Patients are recruited from 17
      primary Health care centres in the south of Sweden. Adult men and women, youth and children ≥
      6 years of age who are visiting the primary Health care for sore throat with suspected
      tonsillitis and meeting the criteria in accordance with current treatment recommendations for
      pharyngotonsillitis, ie 3-4 Centor criteria (fever≥ 38.5, tender lymph nodes, coatings of the
      tonsils and absence of cough) and a positive rapid antigen detection test (RADT) for Group A
      streptococcus (GAS) will be included in the study. Patients will be randomized to be
      prescribed PcV of 5 and 10 days. Each patient or guardian fills daily in a short diary
      including aches, fever, PcV doses, pain relievers, adverse events etc. Five to seven days
      after last intake of PcV the general practioner make a clinical judgement if the patient has
      recovered from the pharyngotonsillitis. Questions to be asked are if remaining symptoms or
      new symptoms of sore throat is present, if adverse events have been noted or of any extra
      physician visits have been made. Throat swab for semi quantitative cultures of Streptococcus
      group A, C and G are made at randomization and five to seven days after last intake of PcV. A
      study nurse will contact the patients one month and three months after the last treatment day
      for follow-up. If the patient has reconsulted or been hospitalised for a sore throat or
      possible complication, those patient records will be examined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical cure</measure>
    <time_frame>5-7 days after discontinuation of treatment</time_frame>
    <description>Difference between treatment groups in the rate of clinical cure. Clinical cure is defined as clinical judgement by physician and absence of Centor criteria (coating, fever and swollen Large Granular Lymphocyte glands).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacteriological cure</measure>
    <time_frame>5-7 days after discontinuation of treatment</time_frame>
    <description>Difference between treatment groups in the rate of bacteriological cure, defined as absence of GAS in culture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of relapses</measure>
    <time_frame>1 month after discontinuation of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of complications</measure>
    <time_frame>Within 3 months after discontinuation of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Tonsillitis</condition>
  <arm_group>
    <arm_group_label>5 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phenoxymethylpenicillin 800 mg x 4 for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 days</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenoxymethylpenicillin 1000 mg x 3 for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenoxymethylpenicillin</intervention_name>
    <arm_group_label>5 days</arm_group_label>
    <arm_group_label>10 days</arm_group_label>
    <other_name>Penicillin V</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults, adolescents and children ≥ 6 years of age with verified streptococcal
             pharyngotonsillitis.

        Exclusion Criteria:

          -  Signs of serious infection.

          -  Known hypersensitivity against penicillin.

          -  Chronic disease with effect on the immune response.

          -  Immunosuppressive treatment.

          -  Streptococcal tonsillitis within one month (relapse).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sigvard Mölstad, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katarina Hedin, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Research and Development, Region Kronoberg and Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pär-Daniel Sundvall, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research and Development Unit, Primary Health Care in Southern Älvsborg County and University of Gothenburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlotta Edlund, Professor</last_name>
    <phone>+46102052011</phone>
    <email>charlotta.edlund@folkhalsomyndigheten.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gunilla Skoog, M Sci</last_name>
    <phone>+46102052406</phone>
    <email>gunilla.skoog@folkhalsomyndigheten.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alvesta vårdcentral</name>
      <address>
        <city>Alvesta</city>
        <zip>342 30</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mattias Rööst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Närhälsan Bollebygd vårdcentral</name>
      <address>
        <city>Bollebygd</city>
        <zip>517 36</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Helena Kårestedt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Capio Citykliniken Bunkeflo Hyllie</name>
      <address>
        <city>Bunkeflostrand</city>
        <zip>21840</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Oskar Smede, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentralen Tåbelund</name>
      <address>
        <city>Eslöv</city>
        <zip>241 31</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Närhälsan Fristad vårdcentral</name>
      <address>
        <city>Fristad</city>
        <zip>513 33</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gudrun Greim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentralen Lessebo</name>
      <address>
        <city>Lessebo</city>
        <zip>360 50</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberto Zucconi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Capio Citykliniken Malmö Limhamn</name>
      <address>
        <city>Limhamn</city>
        <zip>216 16</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ulla Wikström, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Löddeköpinge vårdcentral</name>
      <address>
        <city>Löddeköpinge</city>
        <zip>24630</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anders Walldén, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentralen Sorgenfrimottagningen</name>
      <address>
        <city>Malmö</city>
        <zip>214 33</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lisa Esbjörnsson Klemendz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentralen Lundbergsgatan</name>
      <address>
        <city>Malmö</city>
        <zip>21715</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mia Tyrstrup, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Närhälsan Sandared vårdcentral</name>
      <address>
        <city>Sandared</city>
        <zip>518 32</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pär-Daniel Sundvall, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentrlaen Sjöbo</name>
      <address>
        <city>Sjöbo</city>
        <zip>27531</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mikael Karlsson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Närhälsan Billingen vårdcentral</name>
      <address>
        <city>Skövde</city>
        <zip>541 41</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Emma Ottered, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Närhälsan Norrmalm vårdcentral</name>
      <address>
        <city>Skövde</city>
        <zip>541 41</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Micael Elmersson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Närhälsan Södra Ryd</name>
      <address>
        <city>Skövde</city>
        <zip>541 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Karin Rystedt Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vårdcentrlaen Strandbjörket</name>
      <address>
        <city>Växjö</city>
        <zip>351 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Johanna Sandgren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Capio vårdcentralen Hovshaga</name>
      <address>
        <city>Växjö</city>
        <zip>35261</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yasir Mahdi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2016</study_first_submitted>
  <study_first_submitted_qc>March 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2016</study_first_posted>
  <last_update_submitted>November 29, 2016</last_update_submitted>
  <last_update_submitted_qc>November 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Public Health Agency of Sweden</investigator_affiliation>
    <investigator_full_name>Sigvard Mölstad</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Penicillin V</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

